Activ Surgical Announces FDA Clearance for ActivSight Intraoperative Imaging Module

Activ Surgical announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ActivSight Intraoperative Imaging Module for enhanced surgical visualization.

Metrex Surface Disinfectant Portfolio Secures EPA Approval

The U.S. Environmental Protection Agency (EPA) has approved all eight surface disinfectant products made by an infection prevention leader, Metrex, as effective against SARS-CoV-2, the novel coronavirus that causes COVID-19.

Olympus Supports Safety Actions Regarding Surgical Smoke

Olympus has announced its support of The Joint Commission’s recommended safety actions for managing the hazards of exposure to surgical smoke for health care staff in operating rooms.

Exofin Fusion Redesign Receives FDA Approval

Chemence Medical, a leader in medical cyanoacrylate devices and products, announced the U.S. Federal Drug Administration’s (FDA) 510(k) approval of the company’s redesigned exofin fusion skin closure system.

Titan Medical Renames Robotic Surgical System

Titan Medical Inc. has launched a new name and brand identity for its robotic surgical system under development, the Enos robotic single access surgical system.

During the coming weeks, the company will gradually transition to the new Enos brand identity, including on its website and in presentations and other corporate material. Along with the change to the identity of its surgical system, the company will transition to an updated corporate brand identity that, while retaining the Titan Medical name, complements the Enos robotic single access surgical system.

Enos, translated from the Greek language, has the meaning “of one,” which aligns well with Titan’s commitment to single access surgery. Working with an industry-leading branding team, the company determined that while it should retain its corporate name as a valuable asset, the use of “SPORT” as an identity for its surgical system did not accurately reflect the company values and beliefs and the uniqueness of its technology.

“We are excited to share the renaming and branding of our single access surgical system,” said David McNally, president and CEO of Titan Medical Inc. “While our technology focus remains the same, the Enos identity better reflects the company’s belief that a single incision and simplified approach to surgical procedures is better for everyone, bringing immense potential for expanding utilization and the elevation of the standard of care for patients around the world.”

“The new brand identities demonstrate the evolution of Titan Medical and what we are seeking to accomplish in the robotic assisted surgery space; to become the new standard of care in robotic single access surgery,” McNally added. “As we have successfully leveraged our in-depth robotic surgery expertise, technology and intellectual property to establish strategic relationships, and as we have recommenced the development of our surgical system, we believe now is the appropriate time to launch the new brand identities.”

For more information, visit



Submit a Comment

Your email address will not be published. Required fields are marked *